|Articles|November 1, 2002

November 2002
Volume 8
Issue 11

Do Disease Management Programs for Patients With Coronary Heart Disease Make a Difference? Experiences of Nine Practices

Author(s)Mary N. Walsh, MD, Ross J. Simpson, Jr, MD, George J. Wan, PhD, MPH

Download PDF: Do Disease Management Programs for Patients With Coronary Heart Disease Make a Difference? Experiences of Nine Practices

Articles in this issue

about 23 years ago

Article

Pill Splitting

about 23 years ago

Article

Use of a Disease Severity Index for Evaluation of Healthcare Costs and Management of Comorbidities of Patients With Diabetes Mellitus

about 23 years ago

Article

Understanding Changes in Primary Care Clinicians' Satisfaction From Depression Care Activities During Adoption of Selective Serotonin Reuptake Inhibitors

about 23 years ago

Article

State Regulation of Private Health Insurance: Prescription Drug Benefits, Experimental Treatments, and Consumer Protection

about 23 years ago

Article

Antibiotic Resistance: The Iowa Experience

about 23 years ago

Article

When Do Developing Countries Adopt Managed Care Policies and Technologies? Part I: Policies, Experience, and a Framework of Preconditions

about 23 years ago

Article

Therapeutic Options for the Management of Type 2 Diabetes Mellitus

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Do Disease Management Programs for Patients With Coronary Heart Disease Make a Difference? Experiences of Nine Practices

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations

Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026

New Dermatologic Therapies Make Waves at Maui Derm 2026